This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Beijing University of Technology. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Remy Michel Robert: Inventor in Antibody Research
Introduction
Remy Michel Robert is an inventor associated with Clayton, Australia. The supplied information credits Robert with 2 patents focused on antibodies and their potential applications in detecting and treating disease.
Latest Patents
- CXCR2 antibodies and uses thereof. This invention concerns CXCR2-binding antibodies and related fragments, their production, and their potential use in detecting and treating various conditions.
- IL-21 agonist antibodies and methods of treatment using same. This invention concerns antibodies and related fragments that bind to IL-21, their production, and their potential use in detecting and treating conditions, particularly inflammation, infection, and oncology.
Career Highlights
The listed inventions reflect work involving antibody development and therapeutic applications. The supplied information associates Robert with Beijing University of Technology.
Collaborations
The provided information names Charles Reay Mackay and Di Yu as coworkers. These names indicate potential professional connections, but the specific nature of their collaborations is not specified.
Conclusion
Remy Michel Robert’s listed patent work centers on CXCR2- and IL-21-related antibodies, with potential applications in disease detection and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile